第一作者机构：[1]Chinese Acad Med Sci, Canc Hosp, Med Oncol Dept, Natl Canc Ctr, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Shi Y-K.,Li Z-M.,Qing Y.,et al.A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma[J].ANNALS OF ONCOLOGY.2022,33(7):S827-S827.doi:10.1016/j.annonc.2022.07.744.
APA：
Shi, Y-K.,Li, Z-M.,Qing, Y.,Zhang, H.,Jia, Y....&Li, L..(2022).A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma.ANNALS OF ONCOLOGY,33,(7)
MLA：
Shi, Y-K.,et al."A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma".ANNALS OF ONCOLOGY 33..7(2022):S827-S827
医学